| Pain assessment: global use of the Brief Pain Inventory. CS Cleeland, KM Ryan Annals of the Academy of Medicine, Singapore 23 (2), 129-138, 1994 | 7010 | 1994 |
| Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations RH Dworkin, DC Turk, KW Wyrwich, D Beaton, CS Cleeland, JT Farrar, ... The journal of pain 9 (2), 105-121, 2008 | 3811 | 2008 |
| Pain and its treatment in outpatients with metastatic cancer CS Cleeland, R Gonin, AK Hatfield, JH Edmonson, RH Blum, JA Stewart, ... New England Journal of Medicine 330 (9), 592-596, 1994 | 2933 | 1994 |
| The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory TR Mendoza, XS Wang, CS Cleeland, M Morrissey, BA Johnson, ... Cancer 85 (5), 1186-1196, 1999 | 2370 | 1999 |
| Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases RL Daut, CS Cleeland, RC Flanery Pain 17 (2), 197-210, 1983 | 2035 | 1983 |
| When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function RC Serlin, TR Mendoza, Y Nakamura, KR Edwards, CS Cleeland Pain 61 (2), 277-284, 1995 | 1898 | 1995 |
| Assessing symptom distress in cancer patients: the MD Anderson Symptom Inventory CS Cleeland, TR Mendoza, XS Wang, C Chou, MT Harle, M Morrissey, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2000 | 1841 | 2000 |
| Core outcome domains for chronic pain clinical trials: IMMPACT recommendations DC Turk, RH Dworkin, RR Allen, N Bellamy, N Brandenburg, DB Carr, ... Pain 106 (3), 337-345, 2003 | 1588 | 2003 |
| Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain S Keller, CM Bann, SL Dodd, J Schein, TR Mendoza, CS Cleeland The Clinical journal of pain 20 (5), 309-318, 2004 | 1551 | 2004 |
| Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) E Basch, BB Reeve, SA Mitchell, SB Clauser, LM Minasian, AC Dueck, ... Journal of the National Cancer Institute 106 (9), dju244, 2014 | 1154 | 2014 |
| Cancer-related fatigue, version 2.2015 AM Berger, K Mooney, A Alvarez-Perez, WS Breitbart, KM Carpenter, ... Journal of the National Comprehensive Cancer Network 13 (8), 1012-1039, 2015 | 1092 | 2015 |
| Management of Cancer Pain. Clinical Practice Guideline No. 9. AHCPR Publication No. 94-0592. Rockville, MD. Agency for Health Care Policy and Research, US Department of Health … A Jacox, DB Carr, R Payne, CB Berde, W Breitbart, JM Cain Public Health Service 257, 1994 | 1083* | 1994 |
| Physician attitudes and practice in cancer pain management: a survey from the Eastern Cooperative Oncology Group JH Von Roenn, CS Cleeland, R Gonin, AK Hatfield, KJ Pandya Annals of Internal medicine 119 (2), 121-126, 1993 | 1071 | 1993 |
| Randomized trial of short-versus long-course radiotherapy for palliation of painful bone metastases WF Hartsell, CB Scott, DW Bruner, CW Scarantino, RA Ivker, M Roach III, ... Journal of the National Cancer Institute 97 (11), 798-804, 2005 | 1012 | 2005 |
| The brief pain inventory CS Cleeland, KM Ryan User guide, 2009 | 910 | 2009 |
| Measurement of pain by subjective report CS Cleeland Issues in pain measurement/Raven Press, 1989 | 900 | 1989 |
| Validity and reliability of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) AC Dueck, TR Mendoza, SA Mitchell, BB Reeve, KM Castro, LJ Rogak, ... JAMA oncology 1 (8), 1051-1059, 2015 | 892 | 2015 |
| The prevalence and severity of pain in cancer RL Daut, CS Cleeland Cancer 50 (9), 1913-1918, 1982 | 830 | 1982 |
| Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing JL Gabrilove, CS Cleeland, RB Livingston, B Sarokhan, E Winer, ... Journal of clinical oncology 19 (11), 2875-2882, 2001 | 808 | 2001 |
| Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials C Quinten, C Coens, M Mauer, S Comte, MAG Sprangers, C Cleeland, ... The lancet oncology 10 (9), 865-871, 2009 | 741 | 2009 |
